Genotyping and Phylogenetic Analysis of Human Papillomaviruses in Formalin Fixed Paraffin Embedded Sections from Cervical Lesions in Duhok-Iraq
暂无分享,去创建一个
[1] R. Roden,et al. Cervical Cancer Immunotherapy: Facts and Hopes , 2021, Clinical Cancer Research.
[2] S. Rodenhuis,et al. Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site , 2020, British Journal of Cancer.
[3] Moganavelli Singh,et al. Cervical cancer: a meta-analysis, therapy and future of nanomedicine , 2020, Ecancermedicalscience.
[4] M. Capobianchi,et al. The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease , 2020, Frontiers in Immunology.
[5] T. Muderris,et al. HPV genotype distribution among women with normal and abnormal cervical cytology in Turkey , 2019, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.
[6] M. Karimian,et al. Association of Some High-Risk Mucosal Types of Human Papillomavirus with Cutaneous Squamous Cell Carcinoma in an Iranian Population , 2019, Iranian journal of pathology.
[7] Yiqun Liao,et al. Profile of MeltPro® HPV test for human papillomavirus genotyping and cervical precancer screening , 2019, Expert review of molecular diagnostics.
[8] M. Sopian,et al. Obstacles to Implementing the HPV Vaccine: Is it Worth Pursuing or Not? , 2019, Asian Pacific Journal of Cancer Care.
[9] I. Pity,et al. Human Papillomavirus Genotyping among Different Cervical Smears in Duhok/Iraq , 2019, Asian Pacific journal of cancer prevention : APJCP.
[10] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[11] J. Dillner,et al. Towards quality and order in human papillomavirus research. , 2018, Virology.
[12] A. Amirzargar,et al. Retrospective Analysis of Prevalence of High-risk and Low-risk Human Papillomavirus (HPV) Genotypes in Iranian Women During 2013-2016 , 2017 .
[13] S. Jalilian,et al. The Prevalence and Genotype Distribution of Human Papillomavirus Types in the General Female Population in West of Iran , 2017 .
[14] Fabiana Botelho de Miranda Onofre,et al. HPV detection using primers MY09/MY11 and GP5+/GP6+ in patients with cytologic and/or colposcopic changes , 2014 .
[15] M. Shoukri,et al. Human papillomaviruses in cervical specimens of women residing in Riyadh, Saudi Arabia: a hospital-based study. , 2014, Journal of infection in developing countries.
[16] K. Kapila,et al. Viral load of human papillomavirus in women with normal and abnormal cervical cytology in Kuwait. , 2013, Journal of infection in developing countries.
[17] A. Giuliano,et al. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study , 2011, The Lancet.
[18] J. Bogers,et al. Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types , 2007, Journal of cellular and molecular medicine.
[19] U. Liebert,et al. PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[20] F. Bir,et al. [Investigation of human papillomavirus DNA in cervical specimens by hybrid capture assay]. , 2004, Mikrobiyoloji bulteni.
[21] T. Iftner,et al. Chapter 12: Human papillomavirus technologies. , 2003, Journal of the National Cancer Institute. Monographs.
[22] David R. Scott,et al. Improved Amplification of Genital Human Papillomaviruses , 2000, Journal of Clinical Microbiology.
[23] Nadya Y. Ahmed,et al. Prevalence of HPV Immunostaining in Benign, Preneoplastic & Neoplastic Cervical Lesions of Kurdish Women in Erbil City/Kurdistan of Iraq , 2014 .
[24] Sunanda Ghosh,et al. Evaluation of Pap smear , high risk HPV DNA testing in detection of cervical neoplasia with colposcopy guided or conventional biopsy as gold standard , 2014 .